Important: This version of the e-Laws website will be upgraded to a new version in the coming weeks.
You can try the beta version of the new e-Laws at ontario.ca/laws-beta.
O. Reg. 135/18: DESIGNATION OF DISEASES
filed March 29, 2018 under Health Protection and Promotion Act, R.S.O. 1990, c. H.7
Skip to contentontario regulation 135/18
made under the
Health Protection and Promotion Act
Made: March 19, 2018
Filed: March 29, 2018
Published on e-Laws: April 3, 2018
Printed in The Ontario Gazette: April 14, 2018
Designation of Diseases
Designated diseases
1. For the purposes of the Act, a disease set out in Column 1 of the Table is designated as a disease of public health significance and,
(a) a communicable disease, if it is identified as such in Column 2 of the Table; and
(b) a virulent disease, if it is identified as such in Column 3 of the Table.
Diseases against which immunizing agents are used
2. The following diseases are specified as diseases for the purposes of the definition of “immunizing agent” in subsection 38 (1) of the Act:
1. Diphtheria.
2. Haemophilus influenzae b.
3. Hepatitis A.
4. Hepatitis B.
5. Herpes Zoster.
6. Human Papillomavirus.
7. Influenza.
8. Japanese encephalitis.
9. Measles.
10. Meningococcal.
11. Mumps.
12. Pertussis.
13. Pneumococcal.
14. Poliomyelitis.
15. Rabies.
16. Rotavirus.
17. Rubella.
18. Smallpox.
19. Tetanus.
20. Travellers’ diarrhea.
21. Tuberculosis.
22. Typhoid Fever.
23. Varicella.
24. Yellow Fever.
Revocations
3. The following Regulations are revoked:
1. Ontario Regulation 558/91 (Specification of Communicable Diseases).
2. Ontario Regulation 559/91 (Specification of Reportable Diseases).
3. Ontario Regulation 95/03 (Specification of Virulent Diseases).
Commencement
4. (1) Subject to subsection (2), this Regulation comes into force on the later of the day subsection 14 (4) of Schedule 3 to the Strengthening Quality and Accountability for Patients Act, 2017 comes into force and the day this Regulation is filed.
(2) Section 2 comes into force on the later of the day subsection 2 (5) of Schedule 3 to the Strengthening Quality and Accountability for Patients Act, 2017 comes into force and the day this Regulation is filed.
Table
Designated Diseases
|
Item |
Column 1 Diseases of public health significance |
Column 2 Whether the disease is a communicable disease |
Column 3 Whether the disease is a virulent disease |
|
1. |
Acquired Immunodeficiency Syndrome (AIDS) |
Yes |
No |
|
2. |
Acute Flaccid Paralysis |
No |
No |
|
3. |
Amebiasis |
Yes |
No |
|
4. |
Anthrax |
Yes |
No |
|
5. |
Blastomycosis |
Yes |
No |
|
6. |
Botulism |
Yes |
No |
|
7. |
Brucellosis |
Yes |
No |
|
8. |
Campylobacter enteritis |
Yes |
No |
|
9. |
Carbapenemase-producing Enterobacteriaceae (CPE) infection or colonization |
Yes |
No |
|
10. |
Chancroid |
Yes |
No |
|
11. |
Chickenpox (Varicella) |
Yes |
No |
|
12. |
Chlamydia trachomatis infections |
Yes |
No |
|
13. |
Cholera |
Yes |
Yes |
|
14. |
Clostridium difficile infection (CDI) outbreaks in public hospitals |
Yes |
No |
|
15. |
Creutzfeldt-Jakob Disease, all types |
Yes |
No |
|
16. |
Cryptosporidiosis |
Yes |
No |
|
17. |
Cyclosporiasis |
Yes |
No |
|
18. |
Diphtheria |
Yes |
Yes |
|
19. |
Echinococcus multilocularis infection |
Yes |
No |
|
20. |
Encephalitis, primary, viral |
Yes |
No |
|
21. |
Encephalitis, post-infectious, vaccine-related, subacute sclerosing panencephalitis, unspecified |
No |
No |
|
22. |
Food poisoning, all causes |
Yes |
No |
|
23. |
Gastroenteritis, outbreaks in institutions and public hospitals |
Yes |
No |
|
24. |
Giardiasis, except asymptomatic cases |
Yes |
No |
|
25. |
Gonorrhoea |
Yes |
Yes |
|
26. |
Group A Streptococcal disease, invasive |
Yes |
No |
|
27. |
Group B Streptococcal disease, neonatal |
No |
No |
|
28. |
Haemophilus influenzae disease, all types, invasive |
Yes |
No |
|
29. |
Hantavirus pulmonary syndrome |
Yes |
No |
|
30. |
Hemorrhagic fevers, including: Ebola virus disease, Marburg virus disease, Lassa fever, and other viral causes |
Yes |
Yes |
|
31. |
Hepatitis A, viral |
Yes |
No |
|
32. |
Hepatitis B, viral |
Yes |
No |
|
33. |
Hepatitis C, viral |
Yes |
No |
|
34. |
Influenza |
Yes |
No |
|
35. |
Legionellosis |
Yes |
No |
|
36. |
Leprosy |
Yes |
Yes |
|
37. |
Listeriosis |
Yes |
No |
|
38. |
Lyme Disease |
No |
No |
|
39. |
Measles |
Yes |
No |
|
40. |
Meningitis, acute, including: bacterial, viral and other |
Yes |
No |
|
41. |
Meningococcal disease, invasive |
Yes |
No |
|
42. |
Mumps |
Yes |
No |
|
43. |
Ophthalmia neonatorum |
No |
No |
|
44. |
Paralytic Shellfish Poisoning |
Yes |
No |
|
45. |
Paratyphoid Fever |
Yes |
No |
|
46. |
Pertussis (Whooping Cough) |
Yes |
No |
|
47. |
Plague |
Yes |
Yes |
|
48. |
Pneumococcal disease, invasive |
Yes |
No |
|
49. |
Poliomyelitis, acute |
Yes |
No |
|
50. |
Psittacosis/Ornithosis |
Yes |
No |
|
51. |
Q Fever |
Yes |
No |
|
52. |
Rabies |
Yes |
No |
|
53. |
Respiratory infection outbreaks in institutions and public hospitals |
Yes |
No |
|
54. |
Rubella |
Yes |
No |
|
55. |
Rubella, congenital syndrome |
Yes |
No |
|
56. |
Salmonellosis |
Yes |
No |
|
57. |
Severe Acute Respiratory Syndrome (SARS) |
Yes |
No |
|
58. |
Shigellosis |
Yes |
No |
|
59. |
Smallpox |
Yes |
Yes |
|
60. |
Syphilis |
Yes |
Yes |
|
61. |
Tetanus |
Yes |
No |
|
62. |
Trichinosis |
Yes |
No |
|
63. |
Tuberculosis |
Yes |
Yes |
|
64. |
Tularemia |
Yes |
No |
|
65. |
Typhoid Fever |
Yes |
No |
|
66. |
Verotoxin-producing E. coli infection, including Haemolytic Uraemic Syndrome (HUS) |
Yes |
No |
|
67. |
West Nile Virus Illness |
No |
No |
|
68. |
Yersiniosis |
Yes |
No |
La ministre de la Santé et des Soins de longue durée,
Helena Jaczek
Minister of Health and Long-Term Care
Date made: March 19, 2018
Pris le : 19 mars 2018